Alex Zhavoronkov PhD, Founder & CEO of Insilico Medicine at NextMed Health (http://NextMed.Health) on transforming pharma with end-to-end AI and robotics while solving human aging at the same time.

Insilico Medicine is a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, connects biology, chemistry, and clinical trials analysis using next-generation AI systems. Their mission is to extend healthy productive longevity by transforming drug discovery and development with AI.

More about Alex Zhavoronkov: https://www.nextmed.health/bio-alexzh...

Join the NextMed Health community, catalyze the future and learn what's now, near and next in health and biomedicine: http://NextMed.Health/join